Several such IR procedures require US guidance, but a new study is questioning the modality’s effectiveness in reducing complication rates. 

Three factors are associated with true high-risk findings—imaging protocols for aortic valve implantation planning, imaging area, and cardiology department orders.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

This information could help providers personalize breast cancer screening strategies and initiate treatment earlier.

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

After reviewing years of data from its clinic, one institution discovered that issues with implant data integrity frequently put patients at risk. 

According to new survey data, nonadherence is not for lack of concern about the disease—75% of the women surveyed reported being concerned about their breast health.  

This week, the American Cancer Society’s annual Breast Cancer Statistics report revealed several eye-opening figures.